Philips Medical Systems Nederland B.V. recalled 29 Zenition 50 x-ray systems on September 29, 2025. The devices may suffer from corrosion of the Image Intensifier Television control board, leading to poor image quality. Users must stop using the device immediately and follow the recall instructions.
Over time some systems may experience loss of imaging functionality and/or poor image quality due to potential corrosion of the Image Intensifier Television (IITV) control board.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
The recalled product is the Zenition 50 with Product Number (REF) 718096. It was distributed in the U.S. states of Missouri and Texas, and international locations including Canada and the United Kingdom. The systems were sold before the recall date.
The recall concerns potential loss of imaging functionality and poor image quality. This issue arises from corrosion in the IITV control board, which could affect the diagnostic capabilities of the device.
No specific incidents or injuries have been reported. The recall is preventative due to the potential for degraded imaging.
Patients and healthcare providers should immediately stop using the Zenition 50 x-ray system. Contact Philips Medical Systems Nederland B.V. or your healthcare provider for further instructions.
For questions, reach Philips Medical Systems Nederland B.V. through their official website or customer service number. Additional recall instructions are available on the FDA website.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.